Valvular & structural heart disease
A randomized trial of carbon-dioxide flushing to reduce vascular brain injury in patients undergoing TAVI.
Khawaja et al. · EuroIntervention · 2026 May 20
Latest
Coronary disease & intervention
Novel Mortality Index Unveils Smoking's Role in STEMI Patients Undergoing Primary Percutaneous Coronary Intervention.
Ting et al. · Acta Cardiol Sin · 2026 May
Coronary disease & intervention
P2Y12 inhibitor monotherapy versus dual antiplatelet therapy after complex percutaneous coronary intervention in patients with acute coronary syndromes: a NEO-MINDSET trial substudy.
Prado et al. · EuroIntervention · 2026 May 21
Coronary disease & intervention
Randomized Trial Comparing Radial and Ulnar Access in Single-Catheter Primary Coronary Intervention.
Allaraj et al. · Acta Cardiol Sin · 2026 May
Rhythm & electrophysiology
Implantable Cardioverter-Defibrillator Therapy in Apical Hypertrophic Cardiomyopathy: Insights From a Multicenter Study.
Park et al. · Korean Circ J · 2026 May 12
Coronary disease & intervention
Efficacy and safety of intralesional versus intracoronary administration of glycoprotein IIb/IIIa inhibitors during percutaneous coronary intervention for acute coronary syndromes: a meta-analysis of randomized controlled trials.
Basit et al. · Coron Artery Dis · 2026 May 27
Heart failure & cardiogenic shock
Changes in Pulmonary Artery Pressure Following Initiation of Guideline-Directed Medical Therapies in Patients With Heart Failure: Insights From GUIDE-HF.
Desai et al. · Circ Heart Fail · 2026 May 28
Valvular & structural heart disease
Clinical outcomes following transcatheter aortic valve replacement in patients with concordant versus discordant aortic stenosis.
Hundal et al. · Am Heart J Plus · 2026 Jul
Heart failure & cardiogenic shock
2026 Expert Consensus Recommendations on Hypertrophic Cardiomyopathy: A Report of the Task Force of the Taiwan Society of Cardiology.
Hung et al. · Acta Cardiol Sin · 2026 May
Heart failure & cardiogenic shock
Long-Term Impact of Frailty on Outcomes Following Alcohol Septal Ablation in Hypertrophic Obstructive Cardiomyopathy.
Jain et al. · JACC Adv · 2026 Apr 28
Heart failure & cardiogenic shock
Ethical Considerations for Heart Organ Allocation: Current Landscape and Future Policy Guidance: A Scientific Statement From the American Heart Association.
Khazanie et al. · Circulation · 2026 May 28
Coronary disease & intervention
Design of VICTORION-2 Prevent: a randomized double-blind, placebo-controlled trial, assessing the impact of inclisiran on major adverse cardiovascular events in patients with established cardiovascular disease.
Steg et al. · Am Heart J · 2026 May 26